Federation des caisses Desjardins du Quebec’s Sophiris Bio, Inc. SPHS Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-182	Closed	-$67	–	2442
2019 Q4	$67	Hold	182	–	–	﹤0.01%	2284
2019 Q3	$106	Hold	182	–	–	﹤0.01%	2244
2019 Q2	$154	Hold	182	–	–	﹤0.01%	2220
2019 Q1	$180	Hold	182	–	–	﹤0.01%	2036
2018 Q4	$151	Hold	182	–	–	﹤0.01%	2039
2018 Q3	$508	Hold	182	–	–	﹤0.01%	2078
2018 Q2	$511	Hold	182	–	–	﹤0.01%	2100
2018 Q1	$366	Hold	182	–	–	﹤0.01%	2105
2017 Q4	$413	Hold	182	–	–	﹤0.01%	2082
2017 Q3	$391	Hold	182	–	–	﹤0.01%	2033
2017 Q2	$400	Hold	182	–	–	﹤0.01%	2097
2017 Q1	$515	Buy	+182	New	+$499	﹤0.01%	1727

Other funds holding SPHS

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

ACM

AUA Capital Management Camp Hill, Pennsylvania $216M AUM 19.17% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's SPHS Position: Q1 2020 in Review

Federation des caisses Desjardins du Quebec sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 182 shares — an estimated $67 sold.

Federation des caisses Desjardins du Quebec first reported a position in SPHS in Q1 2017 and held it in 12 quarters. The position peaked at $515 in Q1 2017. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.

Federation des caisses Desjardins du Quebec reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 182 Sophiris Bio, Inc. shares in Q1 2020, an estimated $67.
Federation des caisses Desjardins du Quebec first reported a position in Sophiris Bio, Inc. in Q1 2017 and held it in 12 quarters.
Federation des caisses Desjardins du Quebec's Sophiris Bio, Inc. position peaked at $515 in Q1 2017.
3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2020, filed 30 Aug 2024.